{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:33:20Z","timestamp":1788140000127,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.survophthal.2023.02.003","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T18:39:46Z","timestamp":1676140786000},"page":"628-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Tamoxifen retinopathy"],"prefix":"10.1016","volume":"68","author":[{"given":"Fatemeh","family":"Bazvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Mahdizad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4295-2563","authenticated-orcid":false,"given":"Masoud","family":"Mirghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Riazi-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobeck S.","family":"Modjtahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2023.02.003_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135779","article-title":"Structure and conformation of the carotenoids in human retinal macular pigment","volume":"10","author":"Arteni","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO;2-I","article-title":"Reversible ocular toxicity related to tamoxifen therapy","volume":"61","author":"Ashford","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0003","first-page":"615","article-title":"Optical coherence tomography study in tamoxifen maculopathy","volume":"83","author":"Baget-Bernaldiz","year":"2008","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/13697137.2013.800039","article-title":"Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients","volume":"17","author":"Baumgart","year":"2014","journal-title":"Climacteric"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000485739","article-title":"Tamoxifen use in a patient with idiopathic macular telangiectasia type 2","volume":"9","author":"Behrens","year":"2018","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0006","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1590\/S0004-27492004000400013","article-title":"Multifocal ERG in patients treated with low-dose tamoxifen","volume":"67","author":"Berezovsky","year":"2004","journal-title":"Arquivos Bras Oftalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0007","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/01658100802114380","article-title":"Reversibility of tamoxifen\u00ae retinopathy - a ten-year follow-up","volume":"32","author":"Besch","year":"2008","journal-title":"Neuro-Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0008","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/02713683.2019.1687725","article-title":"The effects of adjuvant tamoxifen use on macula pigment epithelium optical density, visual acuity and retinal thickness in patients with breast cancer","volume":"45","author":"Bicer","year":"2020","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15569527.2020.1734816","article-title":"Retinal structural changes in patients receiving tamoxifen therapy by spectral-domain optical coherence tomography","volume":"39","author":"Bolukbasi","year":"2020","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr-2015-213431","article-title":"To stop or not? Tamoxifen therapy for secondary prevention of breast cancer in a patient with ocular toxicity","volume":"2016","author":"Bommireddy","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0011","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajo.2007.03.023","article-title":"Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy","volume":"144","author":"Bourla","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0012","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2147\/OPTH.S72957","article-title":"Infrared imaging enhances retinal crystals in Bietti's crystalline dystrophy","volume":"9","author":"Brar","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0013","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/mp.54.5.307","article-title":"IGF status is altered by tamoxifen in patients with breast cancer","volume":"54","author":"Campbell","year":"2001","journal-title":"Mol Pathol: MP"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0014","article-title":"Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography","volume":"1","author":"Caramoy","year":"2011","journal-title":"GMS Ophthalmol Cases"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","article-title":"Macular telangiectasia type 2","volume":"34","author":"Charbel Issa","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0016","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1167\/iovs.12-9827","article-title":"Induction of autophagy and cell death by tamoxifen in cultured retinal pigment epithelial and photoreceptor cells","volume":"53","author":"Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3928\/15428877-20100215-06","article-title":"Early detection of tamoxifen-induced maculopathy in patients with low cumulative doses of tamoxifen","volume":"41","author":"Chung","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0018","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/IAE.0000000000002533","article-title":"Tamoxifen-induced chorioretinal changes: an optical coherence tomography and optical coherence tomography angiography study","volume":"40","author":"Cris\u00f3stomo","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0019","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10792-005-5424-3","article-title":"Tamoxifen therapy conveys increased risk of developing a macular hole","volume":"26","author":"Cronin","year":"2005","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0020","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4103\/0973-1482.204888","article-title":"A rare case: Branch retinal vein occlusion associated with the use of tamoxifen","volume":"15","author":"Demirci","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0021","first-page":"52","article-title":"Breast cancer statistics, 2013","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0022","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ajo.2014.02.046","article-title":"Pseudocystic foveal cavitation in tamoxifen retinopathy","volume":"157","author":"Doshi","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0023","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/bjo.88.1.125","article-title":"Short wavelength automated perimetry and tamoxifen use","volume":"88","author":"Eisner","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0024","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3928\/23258160-20170928-10","article-title":"Pachychoroid pigment epitheliopathy associated with tamoxifen","volume":"48","author":"Ersoz","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/ICB.0000000000000691","article-title":"Tamoxifen retinopathy during treatment of an inoperable desmoid tumor","volume":"14","author":"Furst","year":"2020","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0026","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2147\/OPTH.S38951","article-title":"Large bilateral foveal cysts in the inner retina of a patient treated with tamoxifen, diagnosed with Fourier-domain optical coherence tomography","volume":"7","author":"Georgalas","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0027","first-page":"285","article-title":"Tamoxifen induced pachychoroid pigment epitheliopathy with reversible changes after drug discontinuation","volume":"13","author":"Ghassemi","year":"2020","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0028","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.mayocp.2021.01.028","article-title":"Preventing breast cancer through identification and pharmacologic management of high-risk patients","volume":"96","author":"Gilman","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0029","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0002-9394(99)80190-1","article-title":"Long-term tamoxifen citrate use and potential ocular toxicity","volume":"125","author":"Gorin","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ajo.2005.04.042","article-title":"Optical coherence tomography findings in tamoxifen retinopathy","volume":"140","author":"Gualino","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0031","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00347-010-2150-7","article-title":"Unusual symptoms for tamoxifen-associated maculopathy","volume":"107","author":"Hager","year":"2010","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0032","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.oret.2022.08.004","article-title":"Tamoxifen retinopathy and macular telangiectasia type 2 \u2013 similarities and differences on multimodal retinal imaging","volume":"7","author":"Hess","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0033","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pdpdt.2016.10.004","article-title":"The optical imaging and clinical features of tamoxifen associated macular hole: a case report and review of the literatures","volume":"17","author":"Hu","year":"2017","journal-title":"Photodiagn Photodyn Ther"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0034","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jfo.2010.09.017","article-title":"Atrophic tamoxifen maculopathy","volume":"34","author":"Hui-Bon-Hoa","year":"2011","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1590\/S0004-27492005000400025","article-title":"Ocular toxicity caused by tamoxifen: case report","volume":"68","author":"Inada","year":"2005","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0036","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICB.0000000000000093","article-title":"Intravitreal triamcinolone acetonide treatment of tamoxifen maculopathy with associated cystoid macular edema","volume":"9","author":"Jeng","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0037","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1476-5381.1993.tb13840.x","article-title":"Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer","volume":"110","author":"Jordan","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0038","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/02713683.2014.925933","article-title":"Estrogen signalling in the pathogenesis of age-related macular degeneration","volume":"40","author":"Kaarniranta","year":"2015","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0039","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0161-6420(81)35071-4","article-title":"Tamoxifen retinopathy. A clinicopathologic report","volume":"88","author":"Kaiser-Kupfer","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0040","first-page":"315","article-title":"Tamoxifen retinopathy","volume":"62","author":"Kaiser-Kupfer","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0041","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ophtha.2019.10.038","article-title":"Prevalence and risk factors of tamoxifen retinopathy","volume":"127","author":"Kim","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0042","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajoc.2016.05.004","article-title":"The tipping point: tamoxifen toxicity, central serous chorioretinopathy, and the role of estrogen and its receptors","volume":"3","author":"Koulisis","year":"2016","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0043","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1515\/jpem-2013-0052","article-title":"Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review","volume":"26","author":"Lapid","year":"2013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0044","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s004170050139","article-title":"Tamoxifen retinopathy: does it really exist?","volume":"236","author":"Lazzaroni","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.oret.2019.03.014","article-title":"OCT angiography findings of tamoxifen retinopathy: similarity with macular telangiectasia type 2","volume":"3","author":"Lee","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0046","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12886-021-01953-z","article-title":"The response of anti-VEGF therapy and tamoxifen withdrawal of tamoxifen-induced cystoid macular edema in the same patient","volume":"21","author":"Li","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0047","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1167\/iovs.08-2310","article-title":"Effect of Lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia\/reperfusion","volume":"50","author":"Li","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0048","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.breast.2018.04.003","article-title":"Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy","volume":"39","author":"Lim","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0049","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.oftal.2020.05.028","article-title":"Tamoxifen retinal toxicity. Monitoring by multimodal imaging study","volume":"95","author":"Mart\u00ednez","year":"2020","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-006-9187-y","article-title":"Optical coherence tomography in tamoxifen retinopathy","volume":"99","author":"Mauget-Fa\u00ffsse","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0051","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bjo.65.3.177","article-title":"Tamoxifen retinopathy","volume":"65","author":"McKeown","year":"1981","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0052","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1089\/jop.2012.0050","article-title":"The eyes have it! Tamoxifen maculopathy revisited: a case report","volume":"28","author":"Nair","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0053","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/ICB.0b013e31825956f1","article-title":"Spectral domain optical coherence tomography findings in tamoxifen retinopathy\u2014a case report","volume":"7","author":"Nair","year":"2013","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0054","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/OPX.0000000000000478","article-title":"Spectral domain OCT imaging techniques in tamoxifen retinopathy","volume":"92","author":"Neuville","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"Pt 6","key":"10.1016\/j.survophthal.2023.02.003_bib0055","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/eye.1999.217","article-title":"Ocular toxicity in low-dose tamoxifen: a prospective study","volume":"13","author":"Noureddin","year":"1999","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0056","first-page":"1906","article-title":"Estrogen receptor in the human eye: influence of gender and age on gene expression","volume":"40","author":"Ogueta","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0057","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1006132427948","article-title":"Steroid hormone receptors in breast cancer management","volume":"51","author":"Osborne","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0058","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/ICB.0b013e31815e93cf","article-title":"Microcystoid maculopathy associated with tamoxifen use diagnosed by high-resolution fourier-domain optical coherence tomography","volume":"3","author":"Park","year":"2009","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0059","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1034\/j.1600-0420.2003.00116.x","article-title":"Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study","volume":"81","author":"Parkkari","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0060","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W","article-title":"Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients","volume":"69","author":"Pavlidis","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0061","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/annonc\/mdr459","article-title":"Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects","volume":"23","author":"Pemmaraju","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0062","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.ophtha.2010.04.001","article-title":"Perifoveal m\u00fcller cell depletion in a case of macular telangiectasia type 2","volume":"117","author":"Powner","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0063","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/archophthalmol.2011.2741","article-title":"Bevacizumab therapy for tamoxifen-induced crystalline retinopathy and severe cystoid macular edema","volume":"130","author":"Rahimy","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0064","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3126\/nepjoph.v6i2.11713","article-title":"Crystalline deposits in the macula - tamoxifen maculopathy or macular telangiectasia?","volume":"6","author":"Rijal","year":"2014","journal-title":"Nepal J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00347-007-1677-8","article-title":"Tamoxifen retinopathy: a case series of clinical and functional data","volume":"105","author":"Ritter","year":"2008","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0066","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/02713680701229638","article-title":"Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use","volume":"32","author":"Salom\u00e3o","year":"2007","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0067","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1254\/jphs.08039SC","article-title":"Effects of tamoxifen on L-glutamate transporters of astrocytes","volume":"107","author":"Sato","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0068","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.oret.2022.10.014","article-title":"Macular telangiectasia type 2 versus tamoxifen retinopathy: how to hit a diagnostic bullseye","volume":"7","author":"Sauer","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0069","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12886-019-1280-1","article-title":"Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis","volume":"19","author":"Shinkai","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0070","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/humrep\/deh840","article-title":"Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis","volume":"20","author":"Steiner","year":"2005","journal-title":"Hum Reprod"},{"issue":"Pt 3","key":"10.1016\/j.survophthal.2023.02.003_bib0071","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/eye.1997.64","article-title":"Retinal changes associated with tamoxifen treatment for breast cancer","volume":"11","author":"Tang","year":"1997","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr-2017-222093","article-title":"Tamoxifen maculopathy in a male patient","volume":"2017","author":"Temkar","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0073","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/153537020422900704","article-title":"Oxidative stress plays an important role in the pathogenesis of drug-induced retinopathy","volume":"229","author":"Toler","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0074","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1167\/iovs.08-1939","article-title":"Lutein and zeaxanthin measured separately in the living human retina with fundus reflectometry","volume":"49","author":"van de Kraats","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1755-3768.1983.tb01393.x","article-title":"Retinopathy caused by treatment with tamoxifen in low dosage","volume":"61","author":"Vinding","year":"1983","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0076","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s40064-015-1258-2","article-title":"Tamoxifen retinopathy: a case report","volume":"4","author":"Wang","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0077","first-page":"232","article-title":"Ocular toxicity induced by tamoxifen: an overview","volume":"57","author":"Wang","year":"2021","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0078","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-009-9203-8","article-title":"Retinal function in patients treated with tamoxifen","volume":"120","author":"Watanabe","year":"2010","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0079","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10549-012-2089-2","article-title":"Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010","volume":"134","author":"Waters","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0080","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/andr.12197","article-title":"Tamoxifen in men: a review of adverse events","volume":"4","author":"Wibowo","year":"2016","journal-title":"Andrology"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0081","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0002-9394(00)00781-9","article-title":"Tamoxifen retinopathy in a male patient","volume":"131","author":"Yanyali","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-949657","article-title":"Vasodilating mechanisms of testosterone","volume":"115","author":"Yildiz","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.survophthal.2023.02.003_bib0083","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000370144","article-title":"Bilateral macular edema in a patient treated with tamoxifen: a case report and review of the literature","volume":"5","author":"Zafeiropoulos","year":"2014","journal-title":"Case Rep Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723000383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723000383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:56:07Z","timestamp":1758542167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625723000383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0039625723000383"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.02.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tamoxifen retinopathy","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}